Literature DB >> 11256626

Masked antisense: a molecular configuration for discriminating similar RNA targets.

M R Stocks1, T H Rabbitts.   

Abstract

Antisense technology has great potential for the control of RNA expression, but there remain few successful applications of the technology. Expressed antisense RNA can effectively down-regulate expression of a gene over long periods, but cannot differentiate partly identical sequences, such as the mRNA of fusion genes or those with point mutants. We have designed a structured form of expressed antisense, which can discriminate between highly similar mRNA molecules. These 'masked' antisense RNAs have most of the antisense sequence sequestered within duplex elements, leaving a short single-stranded region to initiate binding to target RNA. After contacting the correct target, the structured RNA can unravel, releasing the masked antisense region to form a stable duplex with the mRNA. We demonstrate that suitable masked antisense RNA can discriminate between the two forms of BCR-ABL mRNA that result from the Philadelphia chromosomal translocations, as well as discriminating the normal BCR and ABL mRNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11256626      PMCID: PMC1083679          DOI: 10.1093/embo-reports/kvd003

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  19 in total

1.  BCR-ABL and BCR proteins: biochemical characterization and localization.

Authors:  S Dhut; T Chaplin; B D Young
Journal:  Leukemia       Date:  1990-11       Impact factor: 11.528

2.  Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors:  A Hermans; N Heisterkamp; M von Linden; S van Baal; D Meijer; D van der Plas; L M Wiedemann; J Groffen; D Bootsma; G Grosveld
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

3.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

4.  Improved predictions of secondary structures for RNA.

Authors:  J A Jaeger; D H Turner; M Zuker
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 5.  On finding all suboptimal foldings of an RNA molecule.

Authors:  M Zuker
Journal:  Science       Date:  1989-04-07       Impact factor: 47.728

Review 6.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

7.  Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  C R Bartram; A de Klein; A Hagemeijer; T van Agthoven; A Geurts van Kessel; D Bootsma; G Grosveld; M A Ferguson-Smith; T Davies; M Stone
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

8.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  A de Klein; A G van Kessel; G Grosveld; C R Bartram; A Hagemeijer; D Bootsma; N K Spurr; N Heisterkamp; J Groffen; J R Stephenson
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

9.  The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses.

Authors:  D G Spiller; R V Giles; C M Broughton; J Grzybowski; C J Ruddell; D M Tidd; R E Clark
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1998-08

10.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

View more
  1 in total

1.  Measurements of weak interactions between truncated substrates and a hammerhead ribozyme by competitive kinetic analyses: implications for the design of new and efficient ribozymes with high sequence specificity.

Authors:  Yasuhiro Kasai; Hideki Shizuku; Yasuomi Takagi; Masaki Warashina; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.